AbbVie (ABBV)
(Delayed Data from NYSE)
$181.94 USD
-3.22 (-1.74%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $183.29 +1.35 (0.74%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Brokerage Reports
0 items in cart
AbbVie Inc. [ABBV]
Reports for Purchase
Showing records 101 - 120 ( 382 total )
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for ABBV 111122
Provider: Stock Traders Daily
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for ABBV 11122
Provider: Stock Traders Daily
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended October 21.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended October 14.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for ABBV 102122
Provider: Stock Traders Daily
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for ABBV 101122
Provider: Stock Traders Daily
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for ABBV 10122
Provider: Stock Traders Daily
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended September 23.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended September 16.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for ABBV 92122
Provider: Stock Traders Daily
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for ABBV 91122
Provider: Stock Traders Daily
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended August 26.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for ABBV 9122
Provider: Stock Traders Daily
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for ABBV 82122
Provider: Stock Traders Daily
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for ABBV 81122
Provider: Stock Traders Daily
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended July 29.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for ABBV 8122
Provider: Stock Traders Daily
Analyst: Research Department